Rite Aid

Rite Aid Corp. engages in the ownership and management of retail drug stores. It operates through following segments: Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment includes branded and generic prescription drugs, health and beauty aids, personal care products, and walk-in retail clinics. The Pharmacy Services segment offers transparent and traditional pharmacy benefit management for insurance companies, employers, health plans, and government employee groups. The company was founded by Alex Grass on September 12, 1962 and is headquartered in Philadelphia, PA.

Earnings data Q1 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Rite Aid is a drugstore chain that offers prescription medications, over-the-counter drugs, and health and wellness products. Rite Aid is reshaping the concept of a modern pharmacy by catering to customer demands through various convenient channels, including retail and delivery pharmacy services. Additionally, the company's offerings extend to services provided by its wholly-owned subsidiaries, namely Elixir, Bartell Drugs, and Health Dialog. Elixir, Rite Aid’s pharmacy benefits and services company, encompasses accredited mail and specialty pharmacies, prescription discount programs, and an advanced adjudication platform. These components combine to provide exceptional member experiences and substantial cost savings. Furthermore, Health Dialog delivers healthcare coaching and disease management services through interactive live online sessions and phone-based health services.

Rite Aid is a health products and services company with 2,400 locations across 17 states.

The company's omnichannel business includes digital, retail, and delivery touchpoints. Rite Aid is a top 20 seller of speciality medications, per its investor website.

In addition to its retail business, Rite Aid owns a pharmacy benefits subdivision (Elixir) and a personalized health services and coaching arm, Health Dialog, which has served 10MM members as of May 2022.

The company has reported $1.85 billion of liquidity with no debt maturities until 2025. According to its investor website, Rite Aid expects to be free cash flow (FCF) positive in FY23.

In Q2 2022, Rite Aid shared a three-part growth strategy aimed at deepening market share, expanding into new markets, and creating new offerings.

To grow the current business, Rite Aid is aiming to increase its e-commerce and digital sales, refresh its loyalty program, and grow its specialty pharmacy offering, which focuses on serving customers with complex health conditions.

New market expansion plans include increasing Rite Aid's footprint of "small format" pharmacies in underserved communities and implementing "store within a store" partnerships.

Rite Aid also aims to grow via new offerings, such as expanded health plan and health system clinical services, a pharmacy benefit manager (PBM) as a service offering, and new strategic partnerships.

Rite Aid Investor Relations

*This is not investment advice.

The stock market didn't make major moves on Thursday morning.

Stock Market News: Rite Aid Plans Reverse Split

Rite Aid will start selling CBD creams, lotions and lip balms in Washington and Oregon this month, the company announced Thursday.

Rite Aid will start selling CBD products in 2 states

Rite Aid Corp. (NYSE: RAD) released its fiscal fourth-quarter financial results before the markets opened on Thursday.

Rite Aid Is on the Chopping Block With Q4 Results

Rite Aid's board clears the way for a 1-for-20 reverse stock split later this month. Booking Holdings, LabCorp, and Citi have gone on to move higher after going this route.

Three Stocks That Survived Reverse Splits

Rite Aid (RAD) approves a 1-for-20 reverse stock split to regain compliance for NYSE listing rules. This will reduce the company's outstanding shares to 54 million.

Rite Aid (RAD) Picks 1-for-20 Reverse Stock Split Ratio

Rite Aid on Thursday posted mixed fourth-quarter earnings results and gave a weak forecast for the upcoming fiscal year.

Rite Aid posts a mixed fourth quarter, gives weak full-year forecast

Rite Aid Corp. said late Wednesday that the board has approved a reverse stock split with a ratio of one for 20, which was previously approved by shareholders March 21.

Rite Aid board approves reverse stock split to maintain NYSE listing compliance

Investors approved a move that should keep it on the New York Stock Exchange, but shares have now lost more than 90% of their value over the last three years.

Why Rite Aid Stock Lost 14.2% in March

Rite Aid's results gain from efforts to leverage retail pharmacies and EnvisionRxOptions PBM as well as health and wellness offerings. However, soft outlook for fiscal 2019 concerns investors.

Rite Aid to Post Q4 Earnings: What's in the Offing?

Stock splits are not supposed to matter. That said, investors over the past few decades have viewed it as a heroic move to split a stock as a sign of success as the share price gets higher and higher.

Rite Aid Adopts the Dreaded Reverse Stock Split

Rite Aid shareholders have approved the company's reverse stock split, the company announced Thursday, a move aimed at keeping the drugstore chain's shares trading on New York Stock Exchange.

Rite Aid shareholders approve reverse stock split

Rite Aid Corp. said Thursday that shareholders at its annual meeting have approved a plan for a reverse stock split.

Rite Aid shareholders approve plans for reverse stock split

Rite Aid has cleaned the house in the executive suite, sending its CEO, CFO, and COO packing.

Rite Aid: Cleaned House? Now What?

Rite Aid Corp. announced on Wednesday morning that there will be some changes in its executive leadership as well as some restructuring.

Can Rite Aid Save Itself With This Restructuring?

Struggling drugstore Rite Aid Corporation announced Tuesday afternoon an organizational restructuring and leadership change which prompted a lift in stock price.

Rite Aid Restructuring: CEO, CFO Out Along With 400 Full-Time Jobs

The company expects annual savings of about $55 million from the restructuring, of which about $42 million will be realized within fiscal year 2020.

News for Rite Aid Stock (RAD)